Vol 25, No 6 (2018)
Letters to the Editor — Clinical cardiology
Published online: 2018-12-31
A novel variant of the CASQ2 gene in a Chinese family with catecholaminergic polymorphic ventricular tachycardia
Abstract
Not available
References
- Leenhardt A, Denjoy I, Guicheney P. Catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol. 2012; 5(5): 1044–1052.
- Behere SP, Weindling SN. Catecholaminergic polymorphic ventricular tachycardia: An exciting new era. Ann Pediatr Cardiol. 2016; 9(2): 137–146.
- Venetucci L, Denegri M, Napolitano C, et al. Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nat Rev Cardiol. 2012; 9(10): 561–575.
- Priori SG, Wilde AA, Horie M, et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013; 10(12): e85–108.
- Ge HY, Li XM, Jiang H, et al. [Clinical challenges in the management of catecholaminergic polymorphic ventricular tachycardia in children]. Zhonghua Er Ke Za Zhi. 2017; 55(12): 926–931.
- Hazle MA, Shellhaas RA, Bradley DJ, et al. Arrhythmogenic channelopathy syndromes presenting as refractory epilepsy. Pediatr Neurol. 2013; 49(2): 134–137.
- Paludan-Müller C, Ahlberg G, Ghouse J, et al. Integration of 60,000 exomes and ACMG guidelines question the role of Catecholaminergic Polymorphic Ventricular Tachycardia-associated variants. Clin Genet. 2017; 91(1): 63–72.
